Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dean

Showing results (81-90 of 248) with videos related to

Pageof 25
Sort By:
Schizophrenia Research|August 19, 2006
Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatmentBrian Dean, Geoffrey Pavey, David Thomas, et al.
Journal of Affective Disorders|April 25, 2021
An investigation into nicotinic receptor involvement in mood disorders uncovers novel depression candidate genesAndrew Gibbons, Kate McPherson, Andrea Gogos, et al.
Journal of Affective Disorders|May 19, 2009
Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorderBrian Dean, Nahed Tawadros, Elizabeth Scarr, et al.
Electrophoresis|October 28, 2018
Β-actin does not show the characteristics of a reference protein in human cortexGeorgia M Parkin, Madhara Udawela, Andrew Gibbons, et al.
Journal of Affective Disorders|November 1, 2011
AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorderAndrew Stuart Gibbons, Lucy Brooks, Elizabeth Scarr, et al.
Schizophrenia Research|September 16, 2008
Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1Brian Dean, Andrew Soulby, Geneviève M Evin, et al.
Life Sciences|September 25, 2002
Decreased density of [3H]TCP binding following antipsychotic drug withdrawal in ratsElizabeth Scarr, Fiona-Marie Parkin, Geoffrey Pavey, et al.
Current Neuropharmacology|December 4, 2015
The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Won Je Jeon, Brian Dean, Elizabeth Scarr, et al.
World Journal of Psychiatry|July 11, 2018
Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disordersGeorgia M Parkin, Madhara Udawela, Andrew Gibbons, et al.
General and Comparative Endocrinology|May 27, 2003
Glucocorticoid receptor upregulation during seawater adaptation in a euryhaline teleost, the tilapia (Oreochromis mossambicus)D Brian Dean, Zackary W Whitlow, Russell J Borski
Pageof 25

Showing results (81-90 of 248) with videos related to

Sort By:
Pageof 25
Schizophrenia Research|August 19, 2006
Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatmentBrian Dean, Geoffrey Pavey, David Thomas, et al.
Journal of Affective Disorders|April 25, 2021
An investigation into nicotinic receptor involvement in mood disorders uncovers novel depression candidate genesAndrew Gibbons, Kate McPherson, Andrea Gogos, et al.
Journal of Affective Disorders|May 19, 2009
Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorderBrian Dean, Nahed Tawadros, Elizabeth Scarr, et al.
Electrophoresis|October 28, 2018
Β-actin does not show the characteristics of a reference protein in human cortexGeorgia M Parkin, Madhara Udawela, Andrew Gibbons, et al.
Journal of Affective Disorders|November 1, 2011
AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorderAndrew Stuart Gibbons, Lucy Brooks, Elizabeth Scarr, et al.
Schizophrenia Research|September 16, 2008
Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1Brian Dean, Andrew Soulby, Geneviève M Evin, et al.
Life Sciences|September 25, 2002
Decreased density of [3H]TCP binding following antipsychotic drug withdrawal in ratsElizabeth Scarr, Fiona-Marie Parkin, Geoffrey Pavey, et al.
Current Neuropharmacology|December 4, 2015
The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Won Je Jeon, Brian Dean, Elizabeth Scarr, et al.
World Journal of Psychiatry|July 11, 2018
Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disordersGeorgia M Parkin, Madhara Udawela, Andrew Gibbons, et al.
General and Comparative Endocrinology|May 27, 2003
Glucocorticoid receptor upregulation during seawater adaptation in a euryhaline teleost, the tilapia (Oreochromis mossambicus)D Brian Dean, Zackary W Whitlow, Russell J Borski
Pageof 25